Metrizoate Sodium

CHEMBL1200423 Phase 4 Đã phê duyệt Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
649.9 g/mol
LogP
—
Phase
4

A sodium salt form of metrizoate, sharing the same therapeutic uses.

Khối lượng phân tử

649,9200 g/mol

TPSA

89,50 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)Nc1c(I)c(C(=O)[O-])c(I)c(N(C)C(C)=O)c1I.[Na+]

InChI

InChI=1S/C12H11I3N2O4.Na/c1-4(18)16-10-7(13)6(12(20)21)8(14)11(9(10)15)17(3)5(2)19;/h1-3H3,(H,16,18)(H,20,21);/q;+1/p-1

Molecular Formula

C12H10I3N2NaO4

HBD / HBA

1 / 4

Liên kết có thể quay

3

Nguyên tử nặng

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A sodium salt form of metrizoate, sharing the same therapeutic uses.

Yes, Metrizoate Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200423. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23675747. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.